$13.43
In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan
ALTEYKA chewable tablets 0.12 g

Instruction manual

For medical use of the drug

Altayka

Structure:

Active ingredient: 1 tablet contains the marshmallow root of the dry extract (althaeae radix extractum siccum) (4: 1) - 0.12 g;

excipients: magnesium carbonate, lactose, aspartame (E 951), povidone, orange flavor, magnesium stearate.

Dosage form.

Chewable tablets.

Basic physical and chemical properties: tablets of a grayish-brown color with interspersed, with a flat surface, risk and chamfer.

Pharmacotherapeutic group.

Means used for cough and colds. expectorants. Althea roots.

ATX code R05C A05.

Pharmacological properties.

Pharmacodynamics

Direct-acting expectorant. A herbal preparation that contains marshmallow root dry extract, the main biologically active substances of which are polysaccharides, as well as pectins, amino acids, starch. Polysaccharides of the drug are absorbed into the blood, partially secreted by the bronchial glands and exert an enveloping, softening and anti-inflammatory effect on the mucous membrane of the upper respiratory tract, slightly increasing the release of the liquid component of the bronchial secretion and normalize its rheological properties (viscosity, elasticity, adhesiveness). It enhances the peristaltic movements of the bronchioles and the motor function of the ciliated epithelium of the bronchi, contributing to the elimination of sputum.

Pharmacokinetics

Not studied.

Clinical characteristics.

Indications.

As part of the complex treatment of acute and chronic inflammatory diseases of the respiratory system: laryngitis, tracheitis, bronchitis, bronchial asthma, whooping cough.

Contraindications

Hypersensitivity to the drug, diabetes.

Interaction with other drugs and other types of interactions.

It is not recommended to be used simultaneously with antitussive agents (codeine).

Features of the application.

Patients with rare inherited diseases should not be prescribed as fructose intolerance, glucose-galactose malabsorption syndrome, or sucrose-isomaltose deficiency.

Given the content of aspartame in the composition, it can not be used by patients with phenylketonuria.

Use during pregnancy or lactation.

There is no experience with the use of the drug during pregnancy and lactation.

The ability to influence the reaction rate when driving vehicles or other mechanisms.

Does not affect.

Dosage and administration.

Apply inside. take before meals, chew and drink with a little water.

Adults and children over 14 years of age should be prescribed 1 tablet 4-6 times a day.

Doses for children depending on age are:

7-14 years - 1 tablet 3-4 times a day;

2-7 years - ½ tablets 3-4 times a day.

The duration of treatment is determined by the doctor individually, usually from 7 days to 2 weeks.

Children.

Use in children over 2 years old.

Overdose.

Cases of drug overdose are not described.

Adverse Reactions

In some cases, allergic reactions are possible, including urticaria, itching. in case of any adverse reactions should stop treatment and consult a doctor.

Shelf life.

2 years.

Storage conditions.

Store in a dry place at a temperature not exceeding 25 °c.

Keep out of the reach of children.

Packaging.

No. 20 (10 × 2), No. 50 (10 × 5) in a blister pack.

Vacation category.

Over the counter.

Manufacturer / Applicant.

LLC Ternopharm.

The location of the manufacturer and the address of the place of business.

LLC Ternopharm.

Ukraine, 46010, Ternopol, st. Factory, 4.

ALTEYKA-TERNOFARM syrup

Instruction manual

For medical use of the drug

Altayka-ternofarm

Structure:

Active ingredient: marshmallow root extract dry (4: 1);

5 ml of syrup contains the marshmallow root of the dry extract (Althaeae radix extractum siccum) (4: 1) (extractant - water) in terms of polysaccharides 7.5 mg;

excipients: sodium methylparaben (E 219), sodium propylparaben (E 217), citric acid, confectionery sugar, purified water.

Dosage form.

Syrup.

Basic physical and chemical properties: syrup-like liquid from light brown to red-brown in color with a specific odor. During storage, precipitation is allowed.

Pharmacotherapeutic group.

Means used for cough and colds. expectorants. Althea roots.

ATX code R05C A05.

Pharmacological properties.

Pharmacodynamics

Direct-acting expectorant. Herbal preparation, the main active ingredients of which are polysaccharides, as well as pectins, amino acids, starch and the like. The polysaccharides of the drug are absorbed into the blood, partially secreted by the bronchial glands and exert an enveloping, softening and anti-inflammatory effect on the mucous membrane of the upper respiratory tract, to a certain extent increasing the release of the liquid component of the bronchial secretion and normalizing its rheological properties (viscosity, elasticity, adhesiveness). It enhances the peristaltic movements of the bronchioles and the motor function of the ciliated epithelium of the bronchi, contributing to the elimination of sputum.

Pharmacokinetics

Not studied.

Clinical characteristics.

Indications.

Comprehensive treatment of acute and chronic inflammatory diseases of the respiratory system: laryngitis, tracheitis, bronchitis, bronchial asthma, whooping cough.

Contraindications

Hypersensitivity to the components of the drug.

Interaction with other drugs and other types of interactions.

It is not recommended to be used concurrently with antitussive drugs (e.g. codeine).

Features of the application.

Use during pregnancy or lactation.

The drug is not used, since there is no information on the experience of using the drug during pregnancy and lactation.

The ability to influence the reaction rate when driving vehicles or other mechanisms.

The use of the drug usually does not affect the reaction rate when driving vehicles or other mechanisms.

Dosage and administration.

The drug is taken before meals.

Adults and children over 14 years of age - 15 ml of syrup 4-6 times a day.

Children 6-14 years old - 10 ml of syrup 4-6 times a day.

Children 2-6 years old - 5 ml of syrup 4-6 times a day.

For children aged 2 to 6 years, a certain dose of syrup is diluted in the required amount of boiled water (10-15 ml).

The duration of the course of treatment is determined by the doctor individually, depending on the effectiveness of therapy and usually is 7-14 days.

Children.

The drug is used in children from 2 years.

Overdose.

Cases of drug overdose are not described.

Adverse Reactions

Allergic reactions, increased salivation, irritation of the gastric mucosa are possible. in case of any adverse reactions should stop treatment with the drug and consult a doctor.

Shelf life.

2 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 ° C.

After opening, store no more than 14 days at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Packaging.

100 ml or 200 ml in a bottle; 1 bottle with a measuring spoon or a measured glass in a pack.

Vacation category.

Over the counter.

Manufacturer.

LLC Ternopharm.

Location of the manufacturer and his address of the place of business / location of the applicant.

Ukraine, 46010, Ternopil, st. factory, 4.

Tel./fax: (0352) 521-444, www.ternopharm.com.ua

Tags: Alteyka